{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:25:05Z","timestamp":1763767505049},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,14]]},"DOI":"10.7759\/cureus.30304","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T17:15:32Z","timestamp":1665767732000},"source":"Crossref","is-referenced-by-count":4,"title":["COVID-19 Vaccination-Induced Cholangiopathy and Autoimmune Hepatitis: A Series of Two Cases"],"prefix":"10.7759","author":[{"given":"Mansoor","family":"Zafar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Macken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Parvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Heath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Whibley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Tibble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu R","year":"2020","unstructured":"Lu R, Zhao X, Li J, et al.. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020, 395:565-74. 10.1016\/S0140-6736(20)30251-8","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16554","article-title":"A retrospective observational study: is absolute lymphocyte count a prognostic marker in COVID-19?","volume":"13","author":"Zafar M","year":"2021","unstructured":"Zafar M, Shahbaz M, Karkhanis M, et al.. A retrospective observational study: is absolute lymphocyte count a prognostic marker in COVID-19?. Cureus. 2021, 13:e16554. 10.7759\/cureus.16554","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2021-140564","article-title":"Vitamin D levels and mortality with SARS-COV-2 infection: a retrospective two-centre cohort study","author":"Zafar M","year":"2022","unstructured":"Zafar M, Karkhanis M, Shahbaz M, et al.. Vitamin D levels and mortality with SARS-COV-2 infection: a retrospective two-centre cohort study. 2022. 10.1136\/postgradmedj-2021-140564"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05463-x","article-title":"A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection","author":"Ruan Y","year":"2021","unstructured":"Ruan Y, Ryder RE, De P, et al.. A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection. 2021. 10.1007\/s00125-021-05463-x"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00016-9","article-title":"Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study","volume":"6","author":"Sebastian S","year":"2021","unstructured":"Sebastian S, Walker GJ, Kennedy NA, et al.. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021, 6:271-81. 10.1016\/S2468-1253(21)00016-9","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref6","unstructured":"Scientists use groundbreaking technology in vaccine development. (2022). Accessed. 10\/08\/2022: https:\/\/www.wtkr.com\/news\/scientists-use-groundbreaking-technology-in-vaccine-development."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15490","article-title":"COVID-19 vaccination-induced rash: does the choice of vaccine matter?","volume":"13","author":"Zafar M","year":"2021","unstructured":"Zafar M, Ewnetu B, Ahmed S, Iqbal U, Whitehead M. COVID-19 vaccination-induced rash: does the choice of vaccine matter?. Cureus. 2021, 13:e15490. 10.7759\/cureus.15490","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20979","article-title":"COVID-19 vaccine-induced pneumonitis, myositis and myopericarditis","volume":"14","author":"Farooq M","year":"2022","unstructured":"Farooq M, Mohammed Y, Zafar M, Dharmasena D, Rana UI, Kankam O. COVID-19 vaccine-induced pneumonitis, myositis and myopericarditis. Cureus. 2022, 14:e20979. 10.7759\/cureus.20979","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20932","article-title":"Post COVID-19 vaccine related cerebral venous sinus thrombosis and thrombocytopenia","volume":"14","author":"Butler-Manuel W","year":"2022","unstructured":"Butler-Manuel W, Rana UI, Zafar M, Gadi A, Kiani A. Post COVID-19 vaccine related cerebral venous sinus thrombosis and thrombocytopenia. Cureus. 2022, 14:e20932. 10.7759\/cureus.20932","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?","volume":"75","author":"Bril F","year":"2021","unstructured":"Bril F, Al Diffalha S, Dean M, Fettig DM. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?. J Hepatol. 2021, 75:222-4. 10.1016\/j.jhep.2021.04.003","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.009","article-title":"Autoimmune hepatitis following COVID-19 vaccination: true causality or mere association?","volume":"75","author":"Tan CK","year":"2021","unstructured":"Tan CK, Wong YJ, Wang LM, Ang TL, Kumar R. Autoimmune hepatitis following COVID-19 vaccination: true causality or mere association?. J Hepatol. 2021, 75:1250-2. 10.1016\/j.jhep.2021.06.009","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.044","article-title":"The mRNA COVID-19 vaccine - a rare trigger of autoimmune hepatitis?","volume":"75","author":"McShane C","year":"2021","unstructured":"McShane C, Kiat C, Rigby J, Crosbie \u00d3. The mRNA COVID-19 vaccine - a rare trigger of autoimmune hepatitis?. J Hepatol. 2021, 75:1252-4. 10.1016\/j.jhep.2021.06.044","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.09.031","article-title":"Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed","volume":"76","author":"Zin Tun GS","year":"2022","unstructured":"Zin Tun GS, Gleeson D, Al-Joudeh A, Dube A. Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed. J Hepatol. 2022, 76:747-9. 10.1016\/j.jhep.2021.09.031","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102706","article-title":"Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: a novel clinical entity?","volume":"123","author":"Ghielmetti M","year":"2021","unstructured":"Ghielmetti M, Schaufelberger HD, Mieli-Vergani G, Cerny A, Dayer E, Vergani D, Terziroli Beretta-Piccoli B. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: a novel clinical entity?. J Autoimmun. 2021, 123:102706. 10.1016\/j.jaut.2021.102706","journal-title":"J Autoimmun"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.021","article-title":"SARS-CoV-2 infection in patients with autoimmune hepatitis","volume":"74","author":"Marjot T","year":"2021","unstructured":"Marjot T, Buescher G, Sebode M, et al.. SARS-CoV-2 infection in patients with autoimmune hepatitis. J Hepatol. 2021, 74:1335-43. 10.1016\/j.jhep.2021.01.021","journal-title":"J Hepatol"},{"key":"ref16","unstructured":"Auto-immune hepatitis and Covid-19. (2021). Accessed. 02\/07\/2022: https:\/\/britishlivertrust.org.uk\/auto-immune-hepatitis-and-covid-19\/."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010014","article-title":"RUCAM in drug and herb induced liver injury: the update","volume":"17","author":"Danan G","year":"2015","unstructured":"Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2015, 17:14. 10.3390\/ijms17010014","journal-title":"Int J Mol Sci"},{"key":"ref18","unstructured":"RUCAM scale to estimate the probability of the drug-induced liver injury (DILI) and herb induced liver injury (HILI) online calculator. (2022). Accessed. 10\/08\/2022: https:\/\/clincasequest.hospital\/rucam-scale\/."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31751","article-title":"American Association for the Study of Liver Diseases Expert Panel Consensus Statement: vaccines to prevent coronavirus disease 2019 infection in patients with liver disease","volume":"74","author":"Fix OK","year":"2021","unstructured":"Fix OK, Blumberg EA, Chang KM, et al.. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: vaccines to prevent coronavirus disease 2019 infection in patients with liver disease. Hepatology. 2021, 74:1049-64. 10.1002\/hep.31751","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.032","article-title":"EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients","volume":"74","author":"Cornberg M","year":"2021","unstructured":"Cornberg M, Buti M, Eberhardt CS, Grossi PA, Shouval D. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients. J Hepatol. 2021, 74:944-51. 10.1016\/j.jhep.2021.01.032","journal-title":"J Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro C","year":"2002","unstructured":"Sgro C, Clinard F, Ouazir K, et al.. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002, 36:451-5. 10.1053\/jhep.2002.34857","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson ES","year":"2013","unstructured":"Bj\u00f6rnsson ES, Bergmann OM, Bj\u00f6rnsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013, 144:1419-25, 1425.e1-3; quiz e19-20. 10.1053\/j.gastro.2013.02.006","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0214-RA","article-title":"Drug-induced liver injury","volume":"139","author":"Fisher K","year":"2015","unstructured":"Fisher K, Vuppalanchi R, Saxena R. Drug-induced liver injury. Arch Pathol Lab Med. 2015, 139:876-87. 10.5858\/arpa.2014-0214-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-6-s104","article-title":"Drug-induced liver injury","volume":"16","author":"Katarey D","year":"2016","unstructured":"Katarey D, Verma S. Drug-induced liver injury. Clin Med (Lond). 2016, 16:s104-9. 10.7861\/clinmedicine.16-6-s104","journal-title":"Clin Med (Lond)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00730","article-title":"Idiosyncratic DILI: analysis of 46,266 cases assessed for causality by RUCAM and published from 2014 to early 2019","volume":"10","author":"Teschke R","year":"2019","unstructured":"Teschke R. Idiosyncratic DILI: analysis of 46,266 cases assessed for causality by RUCAM and published from 2014 to early 2019. Front Pharmacol. 2019, 10:730. 10.3389\/fphar.2019.00730","journal-title":"Front Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16491","article-title":"Drug-induced liver injury after COVID-19 vaccine","volume":"13","author":"Mann R","year":"2021","unstructured":"Mann R, Sekhon S, Sekhon S. Drug-induced liver injury after COVID-19 vaccine. Cureus. 2021, 13:e16491. 10.7759\/cureus.16491","journal-title":"Cureus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2022.100140","article-title":"COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature","volume":"5","author":"Camacho-Dom\u00ednguez L","year":"2022","unstructured":"Camacho-Dom\u00ednguez L, Rodr\u00edguez Y, Polo F, Restrepo Gutierrez JC, Zapata E, Rojas M, Anaya JM. COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature. J Transl Autoimmun. 2022, 5:100140. 10.1016\/j.jtauto.2022.100140","journal-title":"J Transl Autoimmun"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.004","article-title":"Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty?","volume":"75","author":"Londo\u00f1o MC","year":"2021","unstructured":"Londo\u00f1o MC, Gratac\u00f3s-Gin\u00e8s J, S\u00e1ez-Pe\u00f1ataro J. Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty?. J Hepatol. 2021, 75:1248-9. 10.1016\/j.jhep.2021.06.004","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.07.005","article-title":"An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: Coincidence, autoimmunity or drug-related liver injury","volume":"75","author":"Lodato F","year":"2021","unstructured":"Lodato F, Larocca A, D'Errico A, Cennamo V. An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: Coincidence, autoimmunity or drug-related liver injury. J Hepatol. 2021, 75:1254-6. 10.1016\/j.jhep.2021.07.005","journal-title":"J Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.014","article-title":"Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine","volume":"75","author":"Clayton-Chubb D","year":"2021","unstructured":"Clayton-Chubb D, Schneider D, Freeman E, Kemp W, Roberts SK. Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. J Hepatol. 2021, 75:1249-50. 10.1016\/j.jhep.2021.06.014","journal-title":"J Hepatol"},{"key":"ref31","unstructured":"Anti-nuclear antibody (ANA). (2022). Accessed. 08\/19\/2022: https:\/\/rheuminfo.com\/common-tests\/anti-nuclear-antibody-ana\/."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15224","article-title":"Autoimmune hepatitis or drug-induced autoimmune hepatitis following Covid-19 vaccination?","volume":"42","author":"Fimiano F","year":"2022","unstructured":"Fimiano F, D'Amato D, Gambella A, Marzano A, Saracco GM, Morgando A. Autoimmune hepatitis or drug-induced autoimmune hepatitis following Covid-19 vaccination?. Liver Int. 2022, 42:1204-5. 10.1111\/liv.15224","journal-title":"Liver Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/119029-covid-19-vaccination-induced-cholangiopathy-and-autoimmune-hepatitis-a-series-of-two-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:33Z","timestamp":1707507693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/119029-covid-19-vaccination-induced-cholangiopathy-and-autoimmune-hepatitis-a-series-of-two-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.30304","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,14]]}}}